Alzheimer's disease: a re-examination of the amyloid hypothesis

[1]  R. Wurtman,et al.  Neuronal Expression of β-Amyloid Precursor Protein Alzheimer Mutations Causes Intracellular Accumulation of a C-terminal Fragment Containing Both the Amyloid β and Cytoplasmic Domains* , 1997, The Journal of Biological Chemistry.

[2]  J. Pettegrew,et al.  Aggregation of β‐Amyloid Peptide Is Promoted by Membrane Phospholipid Metabolites Elevated in Alzheimer's Disease Brain , 1997 .

[3]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[4]  M. Shapiro,et al.  Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.

[5]  I. Grundke‐Iqbal,et al.  Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles , 1997, Molecular Psychiatry.

[6]  R. Reiter,et al.  Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide , 1997, The Journal of Neuroscience.

[7]  H. Nakanishi,et al.  Increased Expression of Cathepsins E and D in Neurons of the Aged Rat Brain and Their Colocalization with Lipofuscin and Carboxy‐Terminal Fragments of Alzheimer Amyloid Precursor Protein , 1997, Journal of neurochemistry.

[8]  H. Wiśniewski,et al.  The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid* , 1996, The Journal of Biological Chemistry.

[9]  T. Sunderland,et al.  Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.

[10]  L. Mucke,et al.  β-Secretase Processing of the β-Amyloid Precursor Protein in Transgenic Mice Is Efficient in Neurons but Inefficient in Astrocytes* , 1996, The Journal of Biological Chemistry.

[11]  G. Elder,et al.  Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene: I. , 1996, Brain research. Molecular brain research.

[12]  R. Neve,et al.  Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.

[13]  Allan I. Levey,et al.  Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo , 1996, Neuron.

[14]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[15]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[16]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[17]  G. Pasinetti.  Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system , 1996, Neurobiology of Aging.

[18]  F. Maxfield,et al.  Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.

[19]  J. Loike,et al.  Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils , 1996, Nature.

[20]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[21]  D. Selkoe,et al.  Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[22]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[23]  H. Soininen,et al.  Apolipoprotein E, memory and Alzheimer's disease , 1996, Trends in Neurosciences.

[24]  S. Takeda,et al.  G Protein-Mediated Neuronal DNA Fragmentation Induced by Familial Alzheimer's Disease-Associated Mutants of APP , 1996, Science.

[25]  P. Gottschall,et al.  Increased Production of Matrix Metalloproteinases in Enriched Astrocyte and Mixed Hippocampal Cultures Treated with β‐Amyloid Peptides , 1996 .

[26]  K. Brunden,et al.  Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro , 1996, Neurobiology of Aging.

[27]  S. Takeda,et al.  Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype. , 1996, The EMBO journal.

[28]  R. Quirion,et al.  Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  M. Lalowski,et al.  Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. , 1996, The Biochemical journal.

[30]  M. V. Hogan,et al.  Surface Phosphorylation by Ecto‐Protein Kinase C in Brain Neurons: A Target for Alzheimer's β‐Amyloid Peptides , 1995, Journal of neurochemistry.

[31]  Carl W. Cotman,et al.  Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro(*) , 1995, The Journal of Biological Chemistry.

[32]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[33]  W. V. Van Nostrand,et al.  Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro(*) , 1995, The Journal of Biological Chemistry.

[34]  C. Arias,et al.  β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices , 1995, Journal of neuroscience research.

[35]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[36]  Mark A. Smith,et al.  Radical AGEing in Alzheimer's disease , 1995, Trends in Neurosciences.

[37]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[38]  J. Whitson,et al.  Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade , 1995, Neurobiology of Aging.

[39]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[40]  J. Poirier.  Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.

[41]  S. Rapoport,et al.  β-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease , 1994, Brain Research.

[42]  A. Privat,et al.  Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures , 1994, Journal of neuroscience research.

[43]  W. Klein,et al.  Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. , 1994, The Journal of biological chemistry.

[44]  L. Thal,et al.  Lack of long-term effects after β-amyloid protein injections in rat brain , 1994, Neurobiology of Aging.

[45]  M. Mattson,et al.  Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation , 1994, Brain Research.

[46]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[47]  C. Behl,et al.  Amyloid β peptide induces necrosis rather than apoptosis , 1994, Brain Research.

[48]  M. Ball,et al.  Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. , 1994, The Journal of biological chemistry.

[49]  D L Alkon,et al.  Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. , 1994, Science.

[50]  J. Morrison,et al.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.

[51]  T. Holzman,et al.  Similarities between β Amyloid Peptides 1-40 and 40-1: Effects on Aggregation, Toxicity in Vitro, and Injection in Young and Aged Rats , 1994, Experimental Neurology.

[52]  R. Porter,et al.  NMDA and AMPA Receptors in Transgenic Mice Expressing Human β‐Amyloid Protein , 1993 .

[53]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[54]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[55]  S. B. Kater,et al.  An analysis of the effects of Alzheimer's plaques on living neurons , 1993, Neurobiology of Aging.

[56]  Khadija Iqbal,et al.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. , 1993, Archives of biochemistry and biophysics.

[57]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[58]  N. Robakis,et al.  The genesis of the senile plaque. Further evidence in support of its neuronal origin. , 1992, The American journal of pathology.

[59]  D. Stephenson,et al.  In vivo effects of β-amyloid implants in rodents: lack of potentiation of damage associated with transient global forebrain ischemia , 1992, Brain Research.

[60]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[61]  G. Carlson,et al.  Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory , 1991, Neuroreport.

[62]  K. Crutcher,et al.  Neurite outgrowth on postmortem human brain cryostat sections: Studies of non-alzheimer's and alzheimer's tissue , 1991, Experimental Neurology.

[63]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[64]  M. Chalfie,et al.  The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration , 1991, Nature.

[65]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[66]  Dagmar Ringe,et al.  A transport problem? , 1990, Nature.

[67]  R. Neve,et al.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.

[68]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[69]  C. Finch,et al.  Molecular Neuropathology of Aging , 1988 .

[70]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[71]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[72]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.